Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 November 2014 11:55
Experts have found that eribulin can extend the lives of women with aggressive forms of breast cancer by several months
Giving breast cancer patients a drug made from sea sponges can extend their lives by several months, according to a new study.
Researchers at the University of Leeds carried out two large-scale trials with more than 1,800 participants who had been diagnosed with metastatic breast cancer.
They found that the drug eribulin extended the women's survival by an average of more than two months.
Women who had advanced triple negative breast cancer - an aggressive form of the disease for which there are few treatment options - benefited the most from the drug, with their lifespans increasing by almost five months.
Those with HER2 negative breast cancer lived more than two months longer when given eribulin, it was found.
Martin Ledwick, head information nurse at Cancer Research UK, described the results as "encouraging" for those women whose cancers no longer respond to conventional treatments.
He said that eribulin is not a cure but an additional option to extend patients' lives - which could be "priceless" for the women and their families. It may give them the option to spend valuable time with their family and friends, or to embark on a holiday with the security provided by specialist travel insurance for cancer patients.
The drug was originally derived from Halichondria okadai, a sea sponge, although it is now produced in laboratories.
Chris Twelves, professor of clinical cancer pharmacology and oncology at the University of Leeds, said the findings show that eribulin can lead to a "substantial improvement" in women's survival rates.
He pointed out that, while the drug was previously only available for women who had undergone several rounds of chemotherapy, the EU has now also approved it for those who have not received as much treatment.
The findings of the study were presented at the National Cancer Research Institute's cancer conference in Liverpool.
18 January 2019
A plant-based diet is needed to protect future generations and safeguard the wellbeing of the planet, according to experts.
[more...]
17 January 2019
Campaigners are protesting outside the High Court in London as the legal challenge against Heathrow Airport's controversial expansion ramps up.
16 January 2019
A new way to predict a woman's risk of breast cancer has been unveiled by scientists - and it's the most comprehensive method yet.
15 January 2019
NHS commissioners could be slapped with a £2,500 fine for every patient left waiting more than a year for vital care, new proposals suggest.
12 January 2019
All UK airports should buy anti-drone technology and not rely on the Royal Air Force to help out, Defence Secretary Gavin Williamson has said.
10 January 2019
The military was brought in on Tuesday night after police officers saw a drone operating at Heathrow Airport, forcing departures to be suspended for an hour.
11 January 2019
A so-called "drug sponge" that mops up leftover drugs from cancer treatment could improve the effectiveness of chemotherapy, new research has claimed.
09 January 2019
A hormone released during exercise could help protect the brain from Alzheimer's disease, new research suggests.
08 January 2019
Ryanair has been labelled the worst airline operating in the UK for the sixth year running in a leading consumer group survey.
05 January 2019
Anti-drone technology will be deployed at the UK's two busiest airports in response to the disruption caused before Christmas.
04 January 2019
A new cancer-detecting breathalyser test is being trialled in the UK - in a move that could revolutionise the way the disease is diagnosed.
03 January 2019
The average 10-year-old child will have already eaten more sugar in their life than the maximum amount recommended for 18-year-olds, a new study reveals.